The abstract is read at the publisher; the summary is JClub's.
Cryab lysine lactylation at K90 is reduced in db/db diabetic cardiomyopathy and, when mutated to K90R, worsens cardiac systolic/diastolic dysfunction, hypertrophy, fibrosis, and apoptosis.
- Why it matters: Diabetic cardiomyopathy is linked to altered myocardial protein regulation and signaling, but how Cryab lactylation controls downstream stress pathways is unclear.
- What they did: In db/db mice and a high-fat diet plus i.p. streptozotocin model, Cryab Kla was assessed in heart tissue and damaged cardiomyocytes; K90R was tested in vivo and in vitro, alongside Hspa1b and MAPK readouts.
- The result: Reduced Cryab Kla is linked to lower Hspa1b stability and reduced Hspa1b protein, with MAPK pathway activation that is further exacerbated by K90R, implying Cryab/Hspa1b/MAPK signaling is Kla-dependent.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.